Health AMGEN ANNOUNCES POSITIVE TOP-LINE RESULTS FROM PHASE 3 STUDY OF ABP 654, BIOSIMILAR CANDIDATE TO STELARA® (USTEKINUMAB) April 18, 2022
Health DEADLINE ALERT for GWGH, ABBV, MYPS, and SDIG: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders April 18, 2022
Health LAWSUITS FILED AGAINST MP, CRNC and ABBV – JAKUBOWITZ LAW PURSUES SHAREHOLDERS CLAIMS April 18, 2022
Health AmoyDx Enters into Master Collaboration Agreement with AstraZeneca for Multiple Companion Diagnostics Programs in China, EU and Japan April 18, 2022
Press Release Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against AbbVie and Twitter and Encourages Investors to Contact the Firm April 17, 2022
Health ROSEN, TRUSTED INVESTOR COUNSEL, Encourages AbbVie Inc. Investors with Losses Exceeding $100K to Secure Counsel Before Important Deadline in Securities Class Action – ABBV April 17, 2022
Health ROSEN, A LEADING, LONGSTANDING, AND TOP RANKED FIRM, Encourages AbbVie Inc. Investors with Losses Over $100K to Secure Counsel Before Important Deadline in Securities Class Action – ABBV April 16, 2022
Health ABBV Shareholder Reminder: Kessler Topaz Meltzer & Check, LLP Reminds Shareholders of AbbVie, Inc. of Deadline in Securities Fraud Class Action Lawsuit April 16, 2022
Search
health sector stocks
